Abstract
Acute herpetic gingivostomatitis and recurrent herpes labialis are the most common manifestations of infection with herpes simplex virus type 1 (HSV-1). In primary and recrudescent HSV-associated disease, the symptoms may range from subclinical to debilitating and life-threatening, depending on the host’s immune responses or competence level. In this paper, the typical and atypical manifestations, and the current diagnostic and treatment options for localized, non-complicated oro-labial HSV infection are reviewed, with attention to cumulative evidence for the ef.cacy and safety of systemic antiviral agents. Some recent data on HSV-1 seroprevalence, viremia, and viral shedding are discussed in relation to disease transmission and global importance of herpesvirus disease.
Similar content being viewed by others
References and Recommended Reading
Embil JA, Stephens RG, Manuel FR: Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents. Can Med Assoc J 1975, 113:627–630.
Celum CL: The interaction between herpes simplex virus and human immunodeficiency virus. Herpes 2004, Suppl 1:36A-45A. Excellent review of evidence and clinical implications of increased risk for HSV acquisition in HSV-infection.
Kent JR, Fraser NW: The cellular response to herpes simplex virus type 1 (HSV-1) during latency and reactivation. J Neurovirol 2005, 11:376–383.
Spear PG: Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol 2004, 6:401–410.
Goodkin ML, Morton ER, Blaho JA: Herpes simplex virus infection and apoptosis. Int Rev Immunol 2004, 23:141–172.
Mohr I: Neutralizing innate host defenses to control viral translation in HSV-1 infected cells. Int Rev Immunol 2004, 23:199–220.
Bystricka M, Russ G: Immunity in latent herpes simplex virus infection. Acta Virol 2005, 49:159–167.
Mori I, Nishiyama Y, Yokochi T, Kimura Y: Olfactory transmission of neurotropic viruses. J Neurovirol 2005, 11:129–137.
Malkin JE: Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 2004, Suppl 1:2A-23A. Excellent comprehensive review; posted by The International Herpes Management Forum, http://www.ihmf.org.
Schillinger JA, Xu F, Sternberg MR, et al.: National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976–1994. Sex Transm Dis 2004, 31:753–760.
Miller CS, Avdiushko SA, Kryscio RJ, et al.: Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment. J Clin Microbiol 2005, 43:2173–280. Excellent example of clinical applicability of PCR detection of HSV-infection and evidence for efficacy of oral antiviral treatment in suppression of recurrence after dental treatment.
Harel L, Smetana Z, Prais D, et al.: Presence of viremia in patients with primary herpetic gingivostomatitis. Clin Infect Dis 2004, 39:636–640.
Namvar L, Olofsson S, Bergstrom T, Lindh M: Detection and typing of Herpes Simplex virus (HSV) in mucocutaneous samples by TaqMan PCR targeting a gB segment homologous for HSV types 1 and 2. J Clin Microbiol 2005, 43:2058–2064.
Birek C: Herpesvirus-induced diseases: oral manifestations and current treatment options. J Calif Dent Assoc 2000, 28:911–921.
Neville BM, Damm DD, Allen CM, Bouquot JF: Oral and Maxillofacial Pathology. Philadelphia: Saunders; 2002.
Waggoner-Fountain LA, Grossman LB: Herpes simplex virus. Pediatr Rev 2004, 25:86–93.
Pardo J, Yogev Y, Ben-Haroush A, et al.: Primary herpes simplex virus type 1 gingivostomatitis during the second and third trimester of pregnancy: foetal and pregnancy outcome. Scand J Infect Dis 2004, 36:179–181.
Epstein JB, Gorsky M, Hancock P, et al.: The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002, 94:712–716.
Raborn GW, Grace MG: Recurrent herpes simplex labialis: selected therapeutic options. J Can Dent Assoc 2003, 69:498–503.
Raborn GW, Martel AY, Lassonde M, et al.: Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. J Am Dent Assoc 2002, 133:303–309.
Eisen D: The clinical characteristics of intraoral herpes simplex virus infection in 52 immunocompetent patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 86:432–437.
Romanowski B, Aoki FY, Martel AY, et al.: Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. AIDS 2000, 14:1211–1217.
Ficarra G, Shillitoes EJ: HIV-related infections of the oral cavity. Crit Rev Oral Biol Med 1992, 3:207–231.
Nikkels AF, Pierard GE: Chronic herpes simplex virus type I glossitis in an immunocompromised man. Br J Dermatol 1999, 140:343–346.
Wollenberg A, Wetzel S, Burgdorf WH, Haas J: Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol 2003, 112:667–674.
Tyler KL: Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret’s. Herpes 2004, Suppl 2:57A-64A. Excellent comprehensive review; posted by The International Herpes Management Forum, http://www.ihmf.org.
Aurelian L, Ono F, Burnett J: Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component. Dermatol Online J 2003, 9:1.
Linder T, Bossart W, Bodmer D: Bell’s palsy and Herpes simplex virus: fact or mystery?. Otol Neurotol 2005, 26:109–113.
Aryee EA, Bailey RL, Natividad-Sancho A, et al.: Detection, quantification and genotyping of Herpes Simplex Virus in cervicovaginal secretions by real-time PCR: a cross sectional survey. Virol J 2005, 11:61. Example of a rapid PCR-based assay to quantify and type HSV in cervicovaginal lavage fluid.
Amir J, Nussinovitch M, Kleper R, et al.: Primary herpes simplex virus type 1 gingivostomatitis in pediatric personnel. Infection 1997, 25:310–312.
Max RE: Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Carol Streem, IL: Quintessence Pub Co; 2003.
Huber MA: Herpes simplex type-1 virus infection. Quintessence Int 2003, 34:453–467.
Kimberlin DW: Herpes simplex virus infections in neonates and early childhood. Semin Pediatr Infect Dis 2005, 16:271–281. This article summarizes the current state of neonatal HSV disease presentation, diagnosis, and management.
Mofenson LM, Oleske J, Serchuck L, et al.: Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. Clin Infect Dis 2005, 40(Suppl 1):S1–84. This comprehensive report focuses on the treatment of opportunistic infections that are common in HIV-exposed and infected infants, children, and adolescents in the United States.
Chilukuri S, Rosen T: Management of acyclovir-resistant herpes simplex virus. Dermatol Clin 2003, 21:311–320.
Wu JJ, Pang KR, Huang DB, Tyring SK: Advances in antiviral therapy. Dermatol Clin 2005, 23:313–322.
Jensen LA, Hoehns JD, Squires CL: Oral antivirals for the acute treatment of recurrent herpes labialis. Ann Pharmacother 2004, 38:705–709.
Spruance SL, Nett R, Marbury T, et al.: Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob Agents Chemother 2002, 46:2238–2243.
Trottet L, Owen H, Holme P, et al.: Are all aciclovir cream formulations bioequivalent? Int J Pharm 2005, 304:63–71.
Bernstein DI, Spruance SL, Arora SS, et al.: Evaluation of imiquimod 5% cream to modify the natural history of herpeslabialis: a pilot study. Clin Infect Dis 2005, 41:808–814.
Sacks SL, Thisted RA, Jones TM, et al.: Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol 2001, 45:222–230.
Simmons A: Clinical manifestations and treatment considerations of herpes simplex virus infection. J Infect Dis 2002, 186(Suppl 1):S71-S77.
Kleymann G: Agents and strategies in development for improved management of herpes simplex virus infection and disease. Expert Opin Investig Drugs 2005, 14:135–161. This excellent review summarizes the current therapeutic options, discusses the potential of preclinical or investigational drugs, and provides an up-to-date interpretation of the challenge to establish novel treatments for herpes simplex disease.
Bernstein D: Glycoprotein D adjuvant herpes simplex virus vaccine. Expert Rev Vaccines 2005, 4:615–627. This review provides an evaluation of the genital HSV-2 glycoprotein D subunit vaccine (formulated with a new adjuvant) and discusses other current approaches to herpes vaccines.
Elish D, Singh F, Weinberg JM: Therapeutic options for herpes labialis, I: oral agents. Cutis 2004, 74:31–34.
Elish D, Singh F, Weinberg JM: Therapeutic options for herpes labialis, II: topical agents. Cutis 2004, 74:35–40.
Spruance SL, Rowe NH, Raborn GW, et al.: Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: a doubleblind, dose-ranging, placebo-controlled, multicenter trial. J Infect Dis 1999, 179:303–310.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Birek, C., Ficarra, G. The diagnosis and management of oral herpes simplex infection. Curr Infect Dis Rep 8, 181–188 (2006). https://doi.org/10.1007/s11908-006-0057-x
Issue Date:
DOI: https://doi.org/10.1007/s11908-006-0057-x